Tarsus Pharmaceuticals, Inc.

Q1 2021 13F Holders

Symbol: TARS
CUSIP: 87650L103
Type: Equity
Class: COM
Num filings: 43
Total reported value, excl. options: $451 M

Compare 2021 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type